The primary objective of the study was to assess the gastric residence time (GRT) of the Soctec capsule after a standardized breakfast. 12 healthy subjects will undergo an initial screening visit. Eligible subjects will undergo the study procedure. The hypothesis is that the GRT of the Soctect Capsule after a standardized breakfast and lunch will be longer compared to literature values reported for a simliar sized capsule.

Inclusion Criteria:

• Male HS, aged between 18 and 50 years.
• Subjects must be in a good health and have BMI between 19 and 25 kg/m2.
• Subjects must be able to read, understand and sign the written informed consent.
• Subjects must be willing and able to comply with study requirements.

Exclusion Criteria:

• History of gastrointestinal, cardiorespiratory (including arterial hypertension), hematologic, renal, atopic, alimentary or psychiatric disorder, panic attacks, diabetes, drug or alcohol abuse.
• Subjects with a history of HIV, hepatitis B or hepatitis C.
• Requiring medication that might alter gut function, including anticholinergics, calcium channel blockers, beta blockers, laxatives, prokinetics, proton-pump inhibitors and non-steroidal anti-inflammatory drugs.
• Prior abdominal surgery other than uncomplicated appendectomy or hernia repair.
• Subject with claustrophobia (fear of small spaces).
• Presence of implants, devices or metallic foreign bodies that might interact with the MRI
• Participation in another investigational study where the study drug was received within 90 days prior to the screening visit.